Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness
Robin Cherian, Bharatendu Chandra, Moon Ley Tung, Alain Vuylsteke
Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020
Respiratory critical care
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Robin Cherian, Bharatendu Chandra, Moon Ley Tung, Alain Vuylsteke. COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness. Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Pathophysiology of central apnoea: how do we distinguish normal from abnormal?
Pathophysiology of pulmonary hypertension: what the interested clinician needs to know
Related content which might interest you:
COPD mechanisms: novel aspects and implications for new therapies
Source: ERS Live 2007
Revising our approach to conducting therapeutic clinical research in COPD
Source: Eur Respir J, 51 (2) 1702712; 10.1183/13993003.02712-2017
A pragmatic guide to choosing biologic therapies in severe asthma
Source: Breathe, 17 (4) 210144; 10.1183/20734735.0144-2021
COPD – will new insights into molecular pathology define new therapies?
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Does acute and persistent metabolic dysregulation in COVID-19 point to novel biomarkers and future therapeutic strategies?
Source: Eur Respir J, 59 (2) 2102417; 10.1183/13993003.02417-2021
HOPE-BAL: A novel tool to expand the methodological capabilities in pulmonary research
Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease
Current and emerging approaches to the genetic diagnosis of chILDs
Source: International Congress 2014 – Interstitial lung disease (ILD) in children
Halotherapy and Covid-19: an oppinion for a possible future prevention approach
Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors
Bronchiectasis: state-of-the-art diagnostic and therapeutic approaches
Source: Virtual Congress 2021 – Respiratory infections
Clinical implications and novel therapies
Source: International Congress 2018 – Accelerated ageing in lungs
From the bedside: upcoming new clinical strategies
Source: International Congress 2016 – Scientific Year in Review 2016
The paradoxes of asthma management: time for a new approach?
Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017
Clinical implications and opportunities for new drug therapies
Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications
The concept of control in COPD: a new proposal for optimising therapy
Source: Eur Respir J 2014; 44: 1072-1075
Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice
Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies
Clinical implications of the new concepts regarding COPD pathophysiology
Source: Annual Congress 2008 - New insights into COPD pathophysiology
Is poor asthma self-management due to failure to recognise symptoms or failure to act? Novel insights from mining large-scale clinical observational study
Source: International Congress 2019 – M-health/e-health II
From staging to therapy: implications of the new staging system with a focus on multi-modal treatment options
Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy
The future: treating specific endotypes
Source: International Congress 2015 – PG2 Asthma and COPD